Oaktree Acquisition III Life Sciences earnings were N/A for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest OACC earnings report on Jun 30, 2025 announced Q2 2025 earnings of $1.9M, up 13% from last quarter.
OACC earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
OACC Return on Equity
Insufficient data to display
OACC undefined
Insufficient data to display
Be the first to know when OACC announces earnings.
Oaktree Acquisition III Life Sciences Earnings Reports & History FAQ
What were Oaktree Acquisition III Life Sciences's earnings last quarter?
Oaktree Acquisition III Life Sciences (NASDAQ: OACC) reported Q2 2025 earnings per share (EPS) of $0.08, up N/A year over year. Total OACC earnings for the quarter were $1.87 million. In the same quarter last year, Oaktree Acquisition III Life Sciences's earnings per share (EPS) was N/A.
Is Oaktree Acquisition III Life Sciences profitable or losing money?
As of the last Oaktree Acquisition III Life Sciences earnings report, Oaktree Acquisition III Life Sciences is currently losing money. Oaktree Acquisition III Life Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2025 was N/A, a N/A decrease year over year.
What was OACC's earnings growth in the past year?
As of Oaktree Acquisition III Life Sciences's earnings date in Q3 2025, Oaktree Acquisition III Life Sciences's earnings has grown year over year. OACC earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.